DEXCOM INC (DXCM) Stock News
NASDAQ:DXCM - Nasdaq - US2521311074 - Common Stock
DXCM Latest News and Analysis
Top S&P500 movers in Thursday's session
Top movers analysis one hour before the close of the markets of S&P500 on 2025-01-16: top gainers and losers in today's session.
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.
Which S&P500 stocks are moving on Thursday?
Nasdaq 100 Movers: TXN, DXCM
S&P 500 Movers: CRL, DXCM
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock?
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
2 Healthcare Stocks to Buy Hand Over Fist in January
2 Healthcare Stocks to Buy Hand Over Fist in January
Instead, as long-term investors know, the key is to hold onto excellent companies that can perform well over the long run. Let's consider two in the healthcare sector: DexCom (NASDAQ: DXCM) and Exact Sciences (NASDAQ: EXAS). Let's discuss why these two companies are worth investing in right now.
Which S&P500 stocks are moving on Tuesday?
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Gapping S&P500 stocks in Tuesday's session
Tuesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market.
Smart rings are one of the hottest consumer electronics categories, as evidenced by exhibitors at CES 2025. Oura leads the market.
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive drop in its stock price overnight. On the other hand, DexCom has attractive opportunities that could allow it to deliver market-beating returns to patient investors.
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
Dexcom and ŌURA Announce Strategic Partnership
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.